Your browser doesn't support javascript.
loading
CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.
Shimizu-Albergine, Masami; Basu, Debapriya; Kanter, Jenny E; Kramer, Farah; Kothari, Vishal; Barnhart, Shelley; Thornock, Carissa; Mullick, Adam E; Clouet-Foraison, Noemie; Vaisar, Tomas; Heinecke, Jay W; Hegele, Robert A; Goldberg, Ira J; Bornfeldt, Karin E.
Afiliación
  • Shimizu-Albergine M; Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medicine Diabetes Institute, University of Washington, Seattle, Washington, USA.
  • Basu D; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA.
  • Kanter JE; Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medicine Diabetes Institute, University of Washington, Seattle, Washington, USA.
  • Kramer F; Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medicine Diabetes Institute, University of Washington, Seattle, Washington, USA.
  • Kothari V; Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medicine Diabetes Institute, University of Washington, Seattle, Washington, USA.
  • Barnhart S; Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medicine Diabetes Institute, University of Washington, Seattle, Washington, USA.
  • Thornock C; Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medicine Diabetes Institute, University of Washington, Seattle, Washington, USA.
  • Mullick AE; Ionis Pharmaceuticals, Carlsbad, California, USA.
  • Clouet-Foraison N; Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medicine Diabetes Institute, University of Washington, Seattle, Washington, USA.
  • Vaisar T; Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medicine Diabetes Institute, University of Washington, Seattle, Washington, USA.
  • Heinecke JW; Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medicine Diabetes Institute, University of Washington, Seattle, Washington, USA.
  • Hegele RA; Robarts Research Institute.
  • Goldberg IJ; Department of Biochemistry, and.
  • Bornfeldt KE; Department of Medicine, Western University, London, Ontario, Canada.
J Clin Invest ; 131(22)2021 11 15.
Article en En | MEDLINE | ID: mdl-34491909
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Triglicéridos / Proteína de Unión a Elemento de Respuesta al AMP Cíclico / Diabetes Mellitus Tipo 1 / Aterosclerosis / Dislipidemias / Lipoproteínas Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Clin Invest Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Triglicéridos / Proteína de Unión a Elemento de Respuesta al AMP Cíclico / Diabetes Mellitus Tipo 1 / Aterosclerosis / Dislipidemias / Lipoproteínas Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Clin Invest Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos